High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.
Loosen SH, Tacke F, Püthe N, Binneboesel M, Wiltberger G, Alizai PH, Kather JN, Paffenholz P, Ritz T, Koch A, Bergmann F, Trautwein C, Longerich T, Roderburg C, Neumann UP, Luedde T.
Loosen SH, et al. Among authors: roderburg c.
Carcinogenesis. 2019 Aug 22;40(8):947-955. doi: 10.1093/carcin/bgz033.
Carcinogenesis. 2019.
PMID: 30805627
Free PMC article.